| Value | ₹0.71 Cr |
|---|---|
| Execution period | 4 years |
BSE filing, NSE: JSL. Summary written from the filing by ALFA Finder's alert engine.
Jindal Stainless Ltd: key numbers
- Share price
- ₹685.85
- Market cap
- ₹56,543 Cr
- Revenue (annual)
- ₹42,955 Cr
- Net profit (annual)
- ₹3,193 Cr
- P/E (TTM)
- 16.9×Sector 17.2×
- Promoter holding
- 62.55%+0.50% QoQ
- FII holding
- 20.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jindal Stainless Ltd
All →Jindal Stainless Promoter Buying: ₹31.23 Cr
JSL Overseas Holding Limited, part of the promoter group, acquired 4,60,493 equity shares of Jindal Stainless Ltd. The market purchase, valued at ₹31.23 Crore, increased their stake to 17.77%.
- Value
- ₹31.23 Cr
- Promoter stake change
- +0.06%
Jindal Stainless Promoter Buying: ₹46.61 Cr
Promoter JSL Overseas Holding bought 6,77,316 Jindal Stainless shares on NSE at ₹46.61 Crore. Promoter stake rose from 17.63% to 17.71%.
- Value
- ₹46.61 Cr
- Promoter stake change
- +0.08%
Jindal Stainless Promoter Buying
JSL Overseas Holding, a Jindal promoter group entity, bought 6,77,316 Jindal Stainless shares on the open market. Its stake rose from 17.63% to 17.71%.
- Promoter stake change
- +0.08%
Jindal Stainless Acquisition Worth ₹5.08 Cr
Jindal Stainless acquired an additional ~7% stake in Ampin C&I Three, taking its holding to 24.21%. The cash cost is ~₹5.08 crore for a 40 MW captive solar project.
- Value
- ₹5.08 Cr
- solar captive capacity
- 40.0 MW
Jindal Stainless Earnings Call Transcript: Key Takeaways
Resilient performance despite gas supply and logistics constraints; focus on premium product mix supported profitability.
Jindal Stainless Investor Presentation: Key Takeaways
Jindal Stainless reported Q2FY27 revenue growth of 18% YoY to ₹12,874 Cr. Management highlights recovery from Q1 geopolitical disruptions and resilient domestic demand across infrastructure and automotive segments.
Other employee stock options announcements
All →Sai Life Science Employee Stock Options
Sai Life Sciences allotted 108,005 ESOP equity shares, taking paid-up capital to Rs.21.26 Crore. No stated consideration means no event value.
Billionbrains Garage Ventures Employee Stock Options
Billionbrains Garage Ventures granted 21,63,086 stock options to eligible employees under its 2024 ESOP scheme. Each option carries an exercise price of Rs. 2 per share.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Zensar Technologies Employee Stock Options
Zensar Technologies allotted 31,440 equity shares to employees on exercise of ESOPs. Paid-up share capital rose to ₹45.55 crore across 22.78 crore shares.
IIFL Finance Employee Stock Options
IIFL Finance allotted 1,97,523 equity shares to eligible employees on exercise of ESOPs, approved by the NRC on 5 November 2026. No cash consideration per share is stated in the filing.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.